Diagnostics boosts Roche's performance
This article was originally published in Clinica
Sales in Roche's diagnostic division increased 28% to SwFr966 million ($654 million) in the year ended December 31. Expressed in local currency terms, this represents 17% growth. Total sales were SwFr18,765 million, up 6% in local currencies.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.